» Articles » PMID: 26932603

Angiopoietin-2-induced Blood-brain Barrier Compromise and Increased Stroke Size Are Rescued by VE-PTP-dependent Restoration of Tie2 Signaling

Abstract

The homeostasis of the central nervous system is maintained by the blood-brain barrier (BBB). Angiopoietins (Ang-1/Ang-2) act as antagonizing molecules to regulate angiogenesis, vascular stability, vascular permeability and lymphatic integrity. However, the precise role of angiopoietin/Tie2 signaling at the BBB remains unclear. We investigated the influence of Ang-2 on BBB permeability in wild-type and gain-of-function (GOF) mice and demonstrated an increase in permeability by Ang-2, both in vitro and in vivo. Expression analysis of brain endothelial cells from Ang-2 GOF mice showed a downregulation of tight/adherens junction molecules and increased caveolin-1, a vesicular permeability-related molecule. Immunohistochemistry revealed reduced pericyte coverage in Ang-2 GOF mice that was supported by electron microscopy analyses, which demonstrated defective intra-endothelial junctions with increased vesicles and decreased/disrupted glycocalyx. These results demonstrate that Ang-2 mediates permeability via paracellular and transcellular routes. In patients suffering from stroke, a cerebrovascular disorder associated with BBB disruption, Ang-2 levels were upregulated. In mice, Ang-2 GOF resulted in increased infarct sizes and vessel permeability upon experimental stroke, implicating a role of Ang-2 in stroke pathophysiology. Increased permeability and stroke size were rescued by activation of Tie2 signaling using a vascular endothelial protein tyrosine phosphatase inhibitor and were independent of VE-cadherin phosphorylation. We thus identified Ang-2 as an endothelial cell-derived regulator of BBB permeability. We postulate that novel therapeutics targeting Tie2 signaling could be of potential use for opening the BBB for increased CNS drug delivery or tighten it in neurological disorders associated with cerebrovascular leakage and brain edema.

Citing Articles

Molecular and Functional Analysis of TLR 1, 2 and 6 in Peripheral Blood Monocytes of Patients with Schizophrenia: A Pilot Study.

Sotelo-Ramirez C, Valdes-Tovar M, Zaragoza-Hoyos J, Ortiz-Lopez L, Argueta J, Rosel-Vales M Int J Mol Sci. 2025; 26(3).

PMID: 39940697 PMC: 11817014. DOI: 10.3390/ijms26030926.


Progression of experimental autoimmune encephalomyelitis in mice and neutrophil-mediated blood-brain barrier dysfunction requires non-muscle myosin light chain kinase.

Beard Jr R, Hoettels B, McAllister J, Meegan J, Wertz T, Self D J Cereb Blood Flow Metab. 2025; :271678X251318620.

PMID: 39917847 PMC: 11806455. DOI: 10.1177/0271678X251318620.


Transendothelial migration of the Lyme disease spirochete involves spirochete internalization as an intermediate step through a transcellular pathway that involves Cdc42 and Rac1.

Alvarez-Olmedo D, Kamaliddin C, Verhey T, Ho M, De Vinney R, Chaconas G Microbiol Spectr. 2024; 13(2):e0222124.

PMID: 39727396 PMC: 11792520. DOI: 10.1128/spectrum.02221-24.


Microglial cell proliferation is regulated, in part, by reactive astrocyte ETB signaling after ischemic stroke.

McInnis J, LeComte M, Reed L, Torsney E, Del Rio-Guerra R, Poynter M Exp Neurol. 2024; 385:115125.

PMID: 39716588 PMC: 11781953. DOI: 10.1016/j.expneurol.2024.115125.


Sturge-Weber syndrome: updates in translational neurology.

Solomon C, Comi A Front Neurol. 2024; 15:1493873.

PMID: 39687400 PMC: 11646805. DOI: 10.3389/fneur.2024.1493873.


References
1.
Salmon A, Neal C, Sage L, Glass C, Harper S, Bates D . Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc Res. 2009; 83(1):24-33. PMC: 2695703. DOI: 10.1093/cvr/cvp093. View

2.
Lee S, Moskowitz M, Sims J . Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts. Int J Mol Med. 2007; 19(3):445-51. View

3.
Mena H, Cadavid D, Rushing E . Human cerebral infarct: a proposed histopathologic classification based on 137 cases. Acta Neuropathol. 2004; 108(6):524-30. DOI: 10.1007/s00401-004-0918-z. View

4.
Paganetti P, Antoniello K, Devraj K, Toni N, Kieran D, Madani R . Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis. J Alzheimers Dis. 2013; 38(4):767-86. DOI: 10.3233/JAD-131091. View

5.
Engelhardt B, Liebner S . Novel insights into the development and maintenance of the blood-brain barrier. Cell Tissue Res. 2014; 355(3):687-99. PMC: 3972432. DOI: 10.1007/s00441-014-1811-2. View